• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

RAS mutation linked with survival in metastatic colorectal cancer

bys25qthea
September 21, 2013
in Chronic Disease, Gastroenterology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: CC/Wiki

1. Patients with colorectal liver metastases (CLM) with a RAS gene mutation were more likely to have cancer recurrence and had lower 3-year survival. 

2. Cancer recurrence in the lung was associated with RAS status, while liver recurrence was not. 

Evidence Rating Level: 2 (Good)            

Study Rundown: In this retrospective cohort study, authors used curative resection specimens from patients with hepatic colorectal metastases to demonstrate an association between RAS mutation and survival as well as cancer recurrence. Strengths of this study include robust sample size and narrow study criteria that only included patients with one round of preoperative chemotherapy with specific agents, thus ensuring participant homogeneity. Though 1406 consecutive CLM patients were treated at MD Anderson, only data from 193 patients was analyzed. The results are thus more difficult to generalize to many CLM patients who receive multiple rounds of preoperative chemotherapy or concomitant radiofrequency ablation.

Click to read the study in Annals of Surgery

RELATED REPORTS

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality

Relevant Reading: KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer

In-Depth [retrospective cohort]: This study analyzed the RAS mutation status of 193 patients with curatively resected hepatic colorectal metastases between 1997 and 2011 with a median follow-up time of 33 months. All patients underwent one round of preoperative chemotherapy. Following laparotomy the resected specimens were examined for somatic mutations using Sequenom’s MassARRAY system. Forty-three patients (22.3%) had a mutation in one the genes assayed and 34 patients (17.6%) were positive for a RAS mutation. Patients with a RAS mutation has lower recurrence-free survival (RFS) at three years compared to patients with wild-type RAS (13.5% vs. 33.5%, p=0.001) and worse overall survival at three years (52.2% vs. 81%, p=0.002). RAS mutation along with poor pathologic response to neoadjuvant chemotherapy were identified as independent risk factors for RFS and overall survival. Tumor recurrence in the lung was also associated with RAS mutation, while liver metastases recurrence was not correlated with RAS status.

By Asya Ofshteyn and Allen Ho

More from this author: Bariatric surgery linked to reversal of diabetes, Postoperative readmission rates correlated with length of stay and ASA class, Prompt surgery may yield better outcomes for adhesive small bowel obstruction, Immediate cholecystectomy preferred treatment for acute cholecystitis, Living donor outcomes improved by motivational interviewing

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: colon cancer
Previous Post

Statin use linked to increased risk of cataracts

Next Post

Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

July 2, 2025
#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer
StudyGraphics

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

June 13, 2025
#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality
StudyGraphics

#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality

April 7, 2025
Development of a risk index for colorectal cancer screening
Chronic Disease

Nivolumab plus ipilimumab improves progression-free survival in metastatic colorectal cancer

April 3, 2025
Next Post
Reducing surgical complications may increase costs

Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer

Breastfeeding associated with decreased risk of childhood obesity

Postnatal breastfeeding concerns associated with discontinuation

Mortality after trauma increasingly due to preexisting conditions

Minorities under-treated in pediatric emergency departments

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.